Amadeus Capital Partners

What they fund

Seed-stage deep tech companies in Intelligence, Human, and Planet sectors [1]., Series A investments in AI-powered drug discovery and advanced computing [1]., Growth-stage companies with large addressable markets and significant technical barriers [1].

Investment thesis

Amadeus Capital Partners is a deep tech venture capital firm established in 1997 that backs trailblazers solving hard problems in large markets.

• Deep Tech Specialization — The core thesis involves backing trailblazers who are solving hard problems in large markets, with a dedicated focus on deep tech since 1997 [1].
• Problem-Solving Orientation — The firm seeks founders addressing significant technical barriers, prioritizing substantive innovation over incremental business model improvements [1].
• Market Scale — Investments are targeted at companies operating within large addressable markets, ensuring sufficient scale for venture returns [1].

Credibility: The firm's homepage explicitly states its focus on deep tech and solving hard problems in large markets, backed by its track record of raising over $1.3 billion for investment and backing more than 200 companies [1].

Value add

Amadeus Capital Partners provides strategic guidance, operational support, and access to its extensive network of industry experts and co-investors. The firm's long track record and deep tech expertise are valuable assets for founders.

Fit verdict: Ideal for deep tech founders with significant technical barriers and large market potential.

Founder diligence script:

• What specific technical barriers does your company address?
• How does your solution leverage deep tech to create a competitive advantage?
• What is your strategy for capturing a large addressable market?
• How does Amadeus Capital Partners' network and expertise align with your company's needs?

Portfolio focus

Intelligence: AI, advanced computing, quantum technologies (e.g., VocalIQ, Sitehop, OKAPI:Orbits) [1]., Human: Health, medicine, wellness (e.g., OrganOx, Igenomix, Healx) [1]., Planet: Sustainability, energy, novel materials, space utilisation (e.g., Paragraf, OrganOx) [1].

Notable investments & exits

OrganOx acquired by Terumo for $1.5 billion in 2025 [1]., Ravelin acquired by Worldpay in 2025 [1]., Cryptosense acquired by SandboxAQ in 2022 [1]., ContactEngine acquired by NICE Systems in 2021 [1]., Igenomix acquired by EQT in 2019 [1].

Strategic implications

Amadeus Capital Partners' deep tech focus and long track record position it as a key player in the UK and European deep tech ecosystem. Its ability to raise significant funds and achieve notable exits demonstrates its effectiveness in identifying and scaling deep tech companies. The firm's partnership with APEX Ventures expands its reach into European deep tech, indicating a strategic move to capitalize on the growing demand for deep tech investments. The firm's focus on large addressable markets suggests a preference for companies with high growth potential and significant market impact.

Where they could go further

Amadeus Capital Partners could expand its geographic focus beyond the UK, US, and Latin America to tap into other high-growth deep tech markets, such as Asia and Europe., The firm could deepen its expertise in emerging deep tech areas, such as biotechnology and climate tech, to stay ahead of the curve and attract top-tier founders., Amadeus Capital Partners could enhance its value proposition by offering more operational support and resources to portfolio companies, particularly in areas like commercialization and go-to-market strategy.